tirzepatide when to increase dose Dosage Chart & Dosing Guide for Weight Loss Navigating Your Path to Health:

(So far, the drugs have been approved for treating type 2 diabetes but not prediabetes.) Are you at risk for type 2 diabetes

Interestingly, DPP-4 inhibitors such as linagliptin or sitagliptin are not associated with delayed gastric emptying and can be considered along with other standard of care agents including SGLT2 inhibitors or insulin in T2DM

E.ZhangR.XuG.et al (2020)

As of 2021, use of GLP-1 medications has surged, with many users taking them for weight loss rather than type 2 diabetes management

GLP-1 agonists (known as GLP-1 receptor agonists to those who study them) are drugs designed to mimic the GLP-1 that your body naturally produces, giving you an extra boost of this Im full hormone